This Nature Communications review argues that rat hepatitis E virus is an emerging zoonotic cause of hepatitis that is likely underdiagnosed because current tests are limited and awareness remains low. It shows that ratHEV is widespread in urban rodent populations, can infect humans and some other animals, and may spread mainly through indirect environmental exposure […]

Hepatitis E viral infection affects transplant patients, with high chronicity and extrahepatic risks. Learn more about screening and treatment strategies.

A new study reveals that nearly half of the pregnant women tested in a northern Indian hospital have been exposed to the Hepatitis E virus, highlighting an urgent need for targeted vaccination and improved sanitation

Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for hepatitis C, was found to block the virus from replicating by disrupting its genetic machinery. Tests in cells and animals showed strong effectiveness without […]

Hepatitis E is responsible for infecting the millions and causing the death of 70,000 people annually. The worst thing is there is no approved treatment and vaccine for hepatitis E. The individuals…

The blood donor screening assay. isdesigned to simultaneously detect and discriminate HIV 1 and 2 and Hepatitis C, B, and E viruses.

In a phase 1 study,ALG-000184 was found to be safe and to have antiviral activity among patients with chronic hepatitis B virus infection, regardless of hepatitis B e-antigen (HBeA

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, increasing laboratory efficiency and decreasing healthcare costs.The new test delivers faster turnaround times and allows labs to implement Hepatitis E (HEV) screening without requiring additional instrumentation.This assay is designed for use on the fully automated cobas x800 […]

Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) – an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.

A drug originally designed to treat hepatitis C is now showing unexpected potential against hepatitis E.

Atea Pharmaceuticals Inc. recently presented preclinical data on two of its compounds, AT-2490 and AT-587, which have shown promising antiviral potential for treating hepatitis E virus infection.

Hepatitis E virus (HEV) is the most common pathogen of acute viral hepatitis. The mechanisms by which HEV enters host cells and is sensed by pattern recognition receptors are largely unexplored. In the present study, filamin A (FLNa), a cytoskeletal protein, was significantly inhibited in patients with HEV infection, animal models, and cell cultures. The […]

Researchers identified bemnifosbuvir as a potential treatment for hepatitis E, finding that it inhibited viral replication in cell models. Animal studies showed efficacy and reduced liver inflammation, providing hope for a novel treatment.

A compound tested for Hepatitis C may offer effective treatment for Hepatitis E potentially saving millions while further trials underway

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of …

Researchers have discovered a compound that prevents hepatitis E viruses from replicating.

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as a compound effective against hepatitis E viruses (HEV). An international research team from Bochum, Germany, Heidelberg, Germany, and Beijing, China, […]

Around 70,000 people die each year from infections with the